The earnings call highlighted significant revenue growth, high gross margins, expansion of active accounts, and important regulatory achievements, such as FDA clearance and FedRAMP authorization. However, the increase in operating expenses and net loss, along with potential impacts from increased tariffs, present challenges. Despite these lowlights, the positive aspects, including strategic achievements and financial growth, suggest a confident outlook.

Company Guidance -

Q3 2025

In the CeriBell, Inc. Q1 2025 earnings call, the company reported a robust start to the year with total revenue of $20.5 million, marking a 42% increase compared to the same period last year. The company experienced 88% gross margin, reflecting its strategic success in account acquisition and utilization. CeriBell added 29 new accounts, reaching a total of 558 active accounts, including its first cohort of VA hospitals. The company also received FedRAMP high authorization, enhancing its cybersecurity credentials. For 2025, CeriBell raised its revenue guidance to $83-$87 million, reflecting an annual growth of 27% to 33%. Despite potential tariff impacts, the company expects to maintain gross margins in the mid-80% range, leveraging its U.S. inventory and cost reduction strategies. The company is also confident in reaching cash flow breakeven with its current cash on hand, totaling $182.7 million as of March 31, 2025.

Strong Revenue Growth

CeriBell, Inc. reported total revenue of $20.5 million for Q1 2025, marking a 42% increase over the same period last year and an 11% increase over Q4 2024.

High Gross Margin

The company achieved a gross margin of 88% in Q1 2025, compared to 86% in the prior year period, indicating strong profitability.

Expansion of Active Accounts

The company increased its active accounts to 558 as of March 31, 2025, adding 29 new accounts in Q1, including the integration of its clarity algorithm in VA hospitals.

FDA Clearance and Product Expansion

CeriBell, Inc. received FDA 510(k) clearance for its Clarity algorithm for seizure detection in pediatric patients, expanding the addressable patient population significantly.

FedRAMP High Authorization Achieved

CeriBell, Inc. received FedRAMP high authorization from the US government, validating its cybersecurity standards and enabling use by other government agencies.

Ceribell, Inc. (CBLL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CBLL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q3)	-0.42 / -	-1.85	―	―	―
Aug 05, 2025	2025 (Q2)	-0.40 / -0.38	-0.372	-2.15% (>-0.01)	―
May 08, 2025	2025 (Q1)	-0.41 / -0.36	―	―	―
Feb 25, 2025	2024 (Q4)	-0.32 / -0.40	―	―	―
Nov 12, 2024	2024 (Q3)	-0.34 / -1.85	―	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CBLL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$15.08	―	―
May 08, 2025	$17.10	$15.97	-6.61%
Feb 25, 2025	$25.54	$25.20	-1.33%
Nov 12, 2024	$28.85	$27.88	-3.36%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ceribell, Inc. (CBLL) report earnings?

Ceribell, Inc. (CBLL) is schdueled to report earning on Nov 18, 2025, After Close (Confirmed).

What is Ceribell, Inc. (CBLL) earnings time?

Ceribell, Inc. (CBLL) earnings time is at Nov 18, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CBLL EPS forecast?

CBLL EPS forecast for the fiscal quarter 2025 (Q3) is -0.42.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing